 "paracetamol, pharma, drugs, medicine, health")
Divi’s Laboratories entered the elite club of companies with a market capitalisation (market-cap) of Rs 1 trillion after the firm's stock price hit a new high of Rs 3,832, up 3 per cent, on Thursday.
The stock of the pharmaceutical company surpassed its previous high of Rs 3,763.40, touched on December 10, 2020.
At 10:05 am, Divi’s Labs' market-capitalisation stood at Rs 1.01 trillion, exchange data show.
Currently, Divis Labs stands at the 30th position among companies having market-cap of over Rs 1 trillion. It is the second most valued pharma company after Sun Pharmaceutical Industries, which has market-cap of
